recombinant igf-1 lr3 IGF-1LR3 – Etho Pharma IGF-1 LR3 - Huma Peptide

Intervention in harmful metabolic pathways by microbial enzyme inhibitors Developing small molecule inhibitors against specific harmful metabolic enzymes encoded by gut microbes is a strategy for precision intervention at the functional level, aiming to block the production of pathogenic metabolites without directly affecting bacterial survival

doi: 10.1164/rccm.201309-1575OC 108 LeeSYLeeJSLeeSWOhY-M

Kornblau SM, Ruvolo P, Qui YH Patel S, Thomas D, Giles F, Beran M, Estrov Z, May WS, Andreeff M

If your needs evolve or your goals shift, your treatment plan evolves with you

doi: 10.1016/j.cell.2012.03.042 29 DoQ.XuL

N.TravisL.KylohM